Display options
Cite
de Groot MJ, Coumans WA, van der Vusse GJ. The nucleotide metabolism in lactate perfused hearts under ischaemic and reperfused conditions. Mol Cell Biochem. 1992;118(1):1-14doi: 10.1007/BF00249689.
de Groot, M. J., Coumans, W. A., & van der Vusse, G. J. (1992). The nucleotide metabolism in lactate perfused hearts under ischaemic and reperfused conditions. Molecular and cellular biochemistry, 118(1), 1-14. https://doi.org/10.1007/BF00249689
de Groot, M J, et al. "The nucleotide metabolism in lactate perfused hearts under ischaemic and reperfused conditions." Molecular and cellular biochemistry vol. 118,1 (1992): 1-14. doi: https://doi.org/10.1007/BF00249689
de Groot MJ, Coumans WA, van der Vusse GJ. The nucleotide metabolism in lactate perfused hearts under ischaemic and reperfused conditions. Mol Cell Biochem. 1992 Dec 02;118(1):1-14. doi: 10.1007/BF00249689. PMID: 1488052.
Copy Download .nbib Format: NLM
Share it on

Mol Cell Biochem. 1992 Dec 02;118(1):1-14. doi: 10.1007/BF00249689.

The nucleotide metabolism in lactate perfused hearts under ischaemic and reperfused conditions.

Molecular and cellular biochemistry

M J de Groot, W A Coumans, G J van der Vusse

Affiliations

  1. Department of Physiology, Cardiovascular Research Institute Maastricht, University of Limburg, The Netherlands.

PMID: 1488052 DOI: 10.1007/BF00249689

Abstract

It was examined whether lactate influences postischaemic hemodynamic recovery as a function of the duration of ischaemia and whether changes in high-energy phosphate metabolism under ischaemic and reperfused conditions could be held responsible for impairment of cardiac function. To this end, isolated working rat hearts were perfused with either glucose (11 mM), glucose (11 mM) plus lactate (5 mM) or glucose (11 mM) plus pyruvate (5 mM). The extent of ischaemic injury was varied by changing the intervals of ischaemia, i.e. 15, 30 and 45 min. Perfusion by lactate evoked marked depression of functional recovery after 30 min of ischaemia. Perfusion by pyruvate resulted in marked decline of cardiac function after 45 min of ischaemia, while in glucose perfused hearts hemodynamic performance was still recovered to some extent after 45 min of ischaemia. Hence, lactate accelerates postischaemic hemodynamic impairment compared to glucose and pyruvate. The marked decline in functional recovery of the lactate perfused hearts cannot be ascribed to the extent of degradation of high-energy phosphates during ischaemia as compared to glucose and pyruvate perfused hearts. Glycolytic ATP formation (evaluated by the rate of lactate production) can neither be responsible for loss of cardiac function in the lactate perfused hearts. Moreover, failure of reenergization during reperfusion, the amount of nucleosides and oxypurines lost or the level of high-energy phosphates at the end of reperfusion cannot explain lactate-induced impairment. Alternatively, the accumulation of endogenous lactate may have contributed to ischaemic damage in the lactate perfused hearts after 30 min of ischaemia as it was higher in the lactate than in the glucose or pyruvate perfused hearts. It cannot be excluded that possible beneficial effects of the elevated glycolytic ATP formation during 15 to 30 min of ischaemia in the lactate perfused hearts are counterbalanced by the detrimental effects of lactate accumulation.

Similar articles

References

  1. Am J Physiol. 1989 Jul;257(1 Pt 2):H47-54 - PubMed
  2. Eur J Biochem. 1986 Aug 15;159(1):203-13 - PubMed
  3. Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 4:777-90 - PubMed
  4. Lab Invest. 1977 Sep;37(3):237-42 - PubMed
  5. Am J Physiol. 1987 May;252(5 Pt 2):H886-93 - PubMed
  6. Circulation. 1989 Nov;80(5):1115-27 - PubMed
  7. Lab Invest. 1974 Jul;31(1):29-33 - PubMed
  8. Biochem J. 1984 Nov 1;223(3):627-32 - PubMed
  9. Science. 1983 Apr 1;220(4592):81-2 - PubMed
  10. Am J Physiol. 1978 May;234(5):H620-4 - PubMed
  11. Biochim Biophys Acta. 1989 Nov 6;1006(1):111-5 - PubMed
  12. J Mol Cell Cardiol. 1990 Jul;22(7):815-26 - PubMed
  13. Anal Biochem. 1985 Jan;144(1):258-66 - PubMed
  14. J Physiol (Paris). 1980;76(7):805-12 - PubMed
  15. Eur J Biochem. 1989 Mar 1;180(1):221-33 - PubMed
  16. Circ Res. 1973 May;32(5):635-42 - PubMed
  17. Cardiovasc Res. 1985 Oct;19(10):593-8 - PubMed
  18. Pflugers Arch. 1988 Dec;413(2):167-73 - PubMed
  19. Acta Med Scand Suppl. 1981;651:19-27 - PubMed
  20. Circ Res. 1984 Dec;55(6):816-24 - PubMed
  21. Cardiovasc Res. 1986 Jan;20(1):67-75 - PubMed
  22. J Am Coll Cardiol. 1988 Jul;12(1):239-49 - PubMed
  23. Free Radic Biol Med. 1988;4(3):163-7 - PubMed
  24. Am J Med. 1963 Dec;35:781-93 - PubMed
  25. Clin Chim Acta. 1981;115(1):73-84 - PubMed
  26. Pflugers Arch. 1991 Aug;419(1):7-12 - PubMed
  27. Lab Invest. 1975 Nov;33(5):502-8 - PubMed

Substances

MeSH terms

Publication Types